HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

New DNA methylation markers and global DNA hypomethylation are associated with oral cancer development.

Abstract
DNA promoter methylation of tumor suppressor genes and global DNA hypomethylation are common features of head and neck cancers. Our goal was to identify early DNA methylation changes in oral premalignant lesions (OPL) that may serve as predictive markers of developing oral squamous cell carcinoma (OSCC). Using high-throughput DNA methylation profiles of 24 OPLs, we found that the top 86 genes differentially methylated between patients who did or did not develop OSCC were simultaneously hypermethylated, suggesting that a CpG island methylation phenotype may occur early during OSCC development. The vast majority of the 86 genes were nonmethylated in normal tissues and hypermethylated in OSCC versus normal mucosa. We used pyrosequencing in a validation cohort of 44 patients to evaluate the degree of methylation of AGTR1, FOXI2, and PENK promoters CpG sites that were included in the top 86 genes and of LINE1 repetitive element methylation, a surrogate of global DNA methylation. A methylation index was developed by averaging the percent methylation of AGTR1, FOXI2, and PENK promoters; patients with a high methylation index had a worse oral cancer-free survival (P = 0.0030). On the other hand, patients with low levels of LINE1 methylation had a significantly worse oral cancer-free survival (P = 0.0153). In conclusion, AGTR1, FOXI2, and PENK promoter methylation and LINE1 hypomethylation may be associated with an increased risk of OSCC development in patients with OPLs.
AuthorsJean-Philippe Foy, Curtis R Pickering, Vassiliki A Papadimitrakopoulou, Jaroslav Jelinek, Steven H Lin, William N William Jr, Mitchell J Frederick, Jing Wang, Wenhua Lang, Lei Feng, Li Zhang, Edward S Kim, You H Fan, Waun K Hong, Adel K El-Naggar, J Jack Lee, Jeffrey N Myers, Jean-Pierre Issa, Scott M Lippman, Li Mao, Pierre Saintigny
JournalCancer prevention research (Philadelphia, Pa.) (Cancer Prev Res (Phila)) Vol. 8 Issue 11 Pg. 1027-35 (Nov 2015) ISSN: 1940-6215 [Electronic] United States
PMID26342026 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright©2015 American Association for Cancer Research.
Chemical References
  • AGTR1 protein, human
  • Receptor, Angiotensin, Type 1
Topics
  • Carcinoma, Squamous Cell (genetics, pathology)
  • Cell Line
  • CpG Islands
  • DNA Methylation
  • Disease Progression
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Mouth Neoplasms (genetics, pathology)
  • Phenotype
  • Precancerous Conditions (genetics, pathology)
  • Promoter Regions, Genetic (genetics)
  • Proportional Hazards Models
  • Receptor, Angiotensin, Type 1 (genetics)
  • Sequence Analysis, DNA

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: